4 Healthcare Stocks Poised to Beat Q2 Earnings Estimates
Expanding aging population and the increasing demand for affordable health products are likely to have boosted the performance of healthcare stocks in Q2. CI, UHS, HCA & THC are potential outperformers.
Here's Why Cigna (CI) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
4 Cheap Stocks to Buy Ahead of Earnings
Cigna, Merck, Toll Brothers, Medtronic could see shares gain after proving their earnings growth remains strong.
Why Cigna (CI) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cigna's Specialty Pharmacy Leadership Expected to Drive Long-Term EPS Growth, Analyst Says
Piper Sandler has initiated coverage on Cigna Corporation CI, a diversified managed care and healthcare delivery organization specializing in commercial insurance markets and pharmacy services.
Why Cigna (CI) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Wall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for June 2024
Fundamentally, the case for strong buy healthcare stocks really sells itself. First off, let's discuss the underlying sector.
Compelling Reasons to Hold on to Cigna (CI) Stock for Now
Cigna (CI) remains well-poised for growth on the back of improved pharmacy revenues in its Evernorth unit. Solid cash-generating abilities also enable it to tactically deploy capital.
The Cigna Group (CI) Management presents at Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
The Cigna Group (NYSE:CI ) Goldman Sachs 45th Annual Global Healthcare Conference June 11, 2024 10:00 AM ET Company Participants Brian Evanko - CFO Conference Call Participants Nathan Rich - Goldman Sachs Nathan Rich Great. Good morning, everyone.
Cigna: Will Benefit From Lower Medicaid Enrollments
Cigna Group's dividend growth potential and strong financial performance make it worth considering for long-term investors. The company's revenue for the quarter grew by 23.3% year over year, with strong growth in its Evernorth Health Services segment. Management's outlook projects a 6% to 9% estimated growth rate for the company, with potential for increased market share and higher revenues.
Is Cigna Group the Nation's Best-Run Health Insurance Company?
Health insurance companies in the medical sector have not fared well in 2024. Medicare Advantage (MA) plans were a bountiful source of income until the second half of 2023.
Cigna's (CI) Express Scripts Collaborates With CPESN USA
Cigna's (CI) Express Scripts collaborates with CPESN USA in a bid to enhance care delivery for hypertension and diabetes patients.
